The top 11 biotechs building for today's market reality

The biotech landscape is evolving, and recognizing the companies positioned to navigate today's challenges requires a sharper lens. Endpoints News is heading to Boston to unveil the 2025 Endpoints 11 — a curated selection of biotech startups and founders who are building with discipline and strategic focus in an increasingly demanding market.

Early bird rate — save $150 — limited in-person tickets
Can’t make it to the event? Virtual passes are available — no charge

Join us for an evening where you'll hear directly from the people behind these companies, understand their strategies, and connect with the investors and industry leaders who are betting on biotech's next phase.

This isn't about flashy promises or easy wins. It's about identifying the teams, science, and approaches that show real potential to create value when capital is scarce and expectations are high. 

We’ll announce the winners live, recognizing the companies our team believes have the best shot at thriving in today’s reality.

Meet the future of biotech — join us.